Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01333644 · ClinicalTrials.gov registry record
The Role of Inflammation and Aging in HIV-Associated Cardiovascular Risk
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 270
- Enrollment target
NCT01333644: Completed study, sponsored by University of California, San Francisco.
NCT01333644 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 270 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01333644 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 270 participants
- Enrollment target
Study Summary
It is the central hypothesis of the investigators study that HIV disease is a pro-inflammatory condition, and that years of inflammation result in premature "aging' of the immune system ("immunosenescence"). Just as these changes are thought be causally associated with heart disease in the very old,the investigators postulate that these changes will be associated with early heart disease in the untreated and perhaps treated HIV disease. To address this hypothesis, the investigators will measure immunosenescence in a large cohort of patients who span the entire disease process.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2010-04 |
| Est. Completion | 2014-12 |
What the finished NCT01333644 record still lists
NCT01333644 is an observational study that tracks outcomes without assigning an intervention. The registered 270 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01333644 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01333644 about?
NCT01333644 is a clinical study titled "The Role of Inflammation and Aging in HIV-Associated Cardiovascular Risk". It is the central hypothesis of the investigators study that HIV disease is a pro-inflammatory condition, and that years of inflammation result in premature "aging' of the immune system ("immunosenescence"). Just as these changes are thought be causally associated with heart disease in the very old,...
What is the current status of trial NCT01333644?
This trial is currently completed. The enrollment target is 270 participants. The study started on 2010-04. Estimated completion is 2014-12.
Who is sponsoring clinical trial NCT01333644?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00801489 · 270 participants · Phase 2
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- NCT04372485 · 270 participants · NA
Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
- NCT04528446 · 270 participants
The Impact of Glomerular Disorders on Bone Quality and Strength
- NCT05215327 · 270 participants · Phase 2
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia